Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Titel:
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Auteur:
Pons-Tostivint, E. Hulo, P. Guardiolle, V. Bodot, L. Rabeau, A. Porte, M. Hiret, S. Demontrond, P. Curcio, H. Boudoussier, A. Veillon, R. Mayenga, M. Dumenil, C. Chatellier, T. Gourraud, P. A. Mazieres, J. Bennouna, J.